MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer

Table 1 Expression of miR-19a and clinicopathological characteristics of patients with gastric cancer n (%)

Variable	Total (n = 50)	Expression of miR-19a
		mean ± SD	P value
Age
< 60	23 (46)	3.58 ± 2.87	0.54
≥ 60	27 (54)	3.42 ± 3.01
Gender
Male	38 (76)	2.90 ± 3.02	0.48
Female	12 (24)	3.15 ± 2.96
TNM stage
T1/T2	19 (38)	2.62 ± 2.63	< 0.05
T3/T4	31 (62)	5.43 ± 1.89
Lymph node metastasis
Positive	30 (60)	5.04 ± 2.30	< 0.05
Negtive	20 (40)	2.09 ± 2.54
Tumor size (cm)
< 5	24 (48)	3.36 ± 2.65	0.66
≥ 5	26 (52)	3.23 ± 2.72
Tobacco
Yes	28 (56)	3.26 ± 2.43	0.18
No	22 (44)	2.97 ± 2.61
Alcohol
Yes	32 (64)	3.35 ± 3.12	0.31
No	18 (36)	3.08 ± 2.94